APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurorehabilitation Exoskeleton Robot

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neurorehabilitation Exoskeleton Robot Market Outlook and Growth Opportunities 2026

25 December 2025193 pages

Choose your research edition.

Industry ResearchNeurorehabilitation Exoskeleton Robot Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurorehabilitation Exoskeleton Robot Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Neurorehabilitation Exoskeleton Robot Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurorehabilitation Exoskeleton Robot Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurorehabilitation Exoskeleton Robot Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Neurorehabilitation Exoskeleton Robot market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neurorehabilitation Exoskeleton Robot is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurorehabilitation Exoskeleton Robot is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurorehabilitation Exoskeleton Robot is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neurorehabilitation Exoskeleton Robot market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neurorehabilitation Exoskeleton Robot market include Shanghai Real Star Rehabilitation Equipment, Shanghai Xirun Medical Equipment, Beijing AI- robotics Technology, Angelexo Scientific, Myomo, Hocoma, Focal Meditech, Ekso Bionics and Bionik, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurorehabilitation Exoskeleton Robot market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurorehabilitation Exoskeleton Robot and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurorehabilitation Exoskeleton Robot sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurorehabilitation Exoskeleton Robot market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurorehabilitation Exoskeleton Robot Segment by Company

Shanghai Real Star Rehabilitation Equipment

Shanghai Xirun Medical Equipment

Beijing AI- robotics Technology

Angelexo Scientific

Myomo

Hocoma

Focal Meditech

Ekso Bionics

Bionik

AlterG

Neurorehabilitation Exoskeleton Robot Segment by Type

Whole Body Rehabilitation Exoskeleton

Upper Limb Rehabilitation Exoskeleton

Lower Limb Rehabilitation Exoskeleton

Neurorehabilitation Exoskeleton Robot Segment by Application

Hospital

Rehabilitation Center

Others

Neurorehabilitation Exoskeleton Robot Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurorehabilitation Exoskeleton Robot status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurorehabilitation Exoskeleton Robot market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurorehabilitation Exoskeleton Robot significant trends, drivers, influence factors in global and regions.

6. To analyze Neurorehabilitation Exoskeleton Robot competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation Exoskeleton Robot market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation Exoskeleton Robot and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation Exoskeleton Robot.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurorehabilitation Exoskeleton Robot market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurorehabilitation Exoskeleton Robot industry.

Chapter 3: Detailed analysis of Neurorehabilitation Exoskeleton Robot manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurorehabilitation Exoskeleton Robot in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurorehabilitation Exoskeleton Robot in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurorehabilitation Exoskeleton Robot Industry Trends Table 2. Neurorehabilitation Exoskeleton Robot Industry Drivers Table 3. Neurorehabilitation Exoskeleton Robot Industry Opportunities and Challenges Table 4. Neurorehabilitation Exoskeleton Robot Industry Restraints Table 5. Global Neurorehabilitation Exoskeleton Robot Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurorehabilitation Exoskeleton Robot Revenue Share by Company (2021-2026) Table 7. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Company (Units) & (2021-2026) Table 8. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Company (2021-2026) Table 9. Global Neurorehabilitation Exoskeleton Robot Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Neurorehabilitation Exoskeleton Robot Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurorehabilitation Exoskeleton Robot Key Company Manufacturing Base & Headquarters Table 12. Global Neurorehabilitation Exoskeleton Robot Company, Product Type & Application Table 13. Global Neurorehabilitation Exoskeleton Robot Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurorehabilitation Exoskeleton Robot by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Whole Body Rehabilitation Exoskeleton Table 18. Significant Companies of Upper Limb Rehabilitation Exoskeleton Table 19. Significant Companies of Lower Limb Rehabilitation Exoskeleton Table 20. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type (2021-2026) & (Units) Table 22. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type (2027-2032) & (Units) Table 23. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Type (2021-2026) Table 24. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Type (2027-2032) Table 25. Global Neurorehabilitation Exoskeleton Robot Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Neurorehabilitation Exoskeleton Robot Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Neurorehabilitation Exoskeleton Robot Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Type (2021-2026) Table 29. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Rehabilitation Center Table 32. Significant Companies of Others Table 33. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application (2021-2026) & (Units) Table 35. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application (2027-2032) & (Units) Table 36. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Application (2021-2026) Table 37. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Application (2027-2032) Table 38. Global Neurorehabilitation Exoskeleton Robot Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Neurorehabilitation Exoskeleton Robot Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Neurorehabilitation Exoskeleton Robot Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Application (2021-2026) Table 42. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Application (2027-2032) Table 43. Global Neurorehabilitation Exoskeleton Robot Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Neurorehabilitation Exoskeleton Robot Sales by Region (2021-2026) & (Units) Table 45. Global Neurorehabilitation Exoskeleton Robot Sales Market Share by Region (2021-2026) Table 46. Global Neurorehabilitation Exoskeleton Robot Sales by Region (2027-2032) & (Units) Table 47. Global Neurorehabilitation Exoskeleton Robot Sales Market Share by Region (2027-2032) Table 48. Global Neurorehabilitation Exoskeleton Robot Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Neurorehabilitation Exoskeleton Robot Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Region (2021-2026) Table 51. Global Neurorehabilitation Exoskeleton Robot Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Region (2027-2032) Table 53. Global Neurorehabilitation Exoskeleton Robot Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Neurorehabilitation Exoskeleton Robot Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Neurorehabilitation Exoskeleton Robot Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Neurorehabilitation Exoskeleton Robot Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Neurorehabilitation Exoskeleton Robot Sales by Country (2021-2026) & (Units) Table 58. Global Neurorehabilitation Exoskeleton Robot Sales Market Share by Country (2021-2026) Table 59. Global Neurorehabilitation Exoskeleton Robot Sales by Country (2027-2032) & (Units) Table 60. Global Neurorehabilitation Exoskeleton Robot Sales Market Share by Country (2027-2032) Table 61. Global Neurorehabilitation Exoskeleton Robot Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Neurorehabilitation Exoskeleton Robot Sales Value Market Share by Country (2021-2026) Table 63. Global Neurorehabilitation Exoskeleton Robot Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Neurorehabilitation Exoskeleton Robot Sales Value Market Share by Country (2027-2032) Table 65. Shanghai Real Star Rehabilitation Equipment Company Information Table 66. Shanghai Real Star Rehabilitation Equipment Business Overview Table 67. Shanghai Real Star Rehabilitation Equipment Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Shanghai Real Star Rehabilitation Equipment Neurorehabilitation Exoskeleton Robot Product Portfolio Table 69. Shanghai Real Star Rehabilitation Equipment Recent Development Table 70. Shanghai Xirun Medical Equipment Company Information Table 71. Shanghai Xirun Medical Equipment Business Overview Table 72. Shanghai Xirun Medical Equipment Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Shanghai Xirun Medical Equipment Neurorehabilitation Exoskeleton Robot Product Portfolio Table 74. Shanghai Xirun Medical Equipment Recent Development Table 75. Beijing AI- robotics Technology Company Information Table 76. Beijing AI- robotics Technology Business Overview Table 77. Beijing AI- robotics Technology Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Beijing AI- robotics Technology Neurorehabilitation Exoskeleton Robot Product Portfolio Table 79. Beijing AI- robotics Technology Recent Development Table 80. Angelexo Scientific Company Information Table 81. Angelexo Scientific Business Overview Table 82. Angelexo Scientific Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Angelexo Scientific Neurorehabilitation Exoskeleton Robot Product Portfolio Table 84. Angelexo Scientific Recent Development Table 85. Myomo Company Information Table 86. Myomo Business Overview Table 87. Myomo Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Myomo Neurorehabilitation Exoskeleton Robot Product Portfolio Table 89. Myomo Recent Development Table 90. Hocoma Company Information Table 91. Hocoma Business Overview Table 92. Hocoma Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Hocoma Neurorehabilitation Exoskeleton Robot Product Portfolio Table 94. Hocoma Recent Development Table 95. Focal Meditech Company Information Table 96. Focal Meditech Business Overview Table 97. Focal Meditech Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Focal Meditech Neurorehabilitation Exoskeleton Robot Product Portfolio Table 99. Focal Meditech Recent Development Table 100. Ekso Bionics Company Information Table 101. Ekso Bionics Business Overview Table 102. Ekso Bionics Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Ekso Bionics Neurorehabilitation Exoskeleton Robot Product Portfolio Table 104. Ekso Bionics Recent Development Table 105. Bionik Company Information Table 106. Bionik Business Overview Table 107. Bionik Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bionik Neurorehabilitation Exoskeleton Robot Product Portfolio Table 109. Bionik Recent Development Table 110. AlterG Company Information Table 111. AlterG Business Overview Table 112. AlterG Neurorehabilitation Exoskeleton Robot Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. AlterG Neurorehabilitation Exoskeleton Robot Product Portfolio Table 114. AlterG Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Neurorehabilitation Exoskeleton Robot Distributors List Table 118. Neurorehabilitation Exoskeleton Robot Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Neurorehabilitation Exoskeleton Robot Product Image Figure 2. Global Neurorehabilitation Exoskeleton Robot Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurorehabilitation Exoskeleton Robot Sales (2021-2032) & (Units) Figure 5. Global Neurorehabilitation Exoskeleton Robot Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Neurorehabilitation Exoskeleton Robot Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Whole Body Rehabilitation Exoskeleton Image Figure 10. Upper Limb Rehabilitation Exoskeleton Image Figure 11. Lower Limb Rehabilitation Exoskeleton Image Figure 12. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Type (2021-2032) Figure 15. Global Neurorehabilitation Exoskeleton Robot Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Neurorehabilitation Exoskeleton Robot Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Rehabilitation Center Image Figure 20. Others Image Figure 21. Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Application (2021-2032) Figure 24. Global Neurorehabilitation Exoskeleton Robot Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Neurorehabilitation Exoskeleton Robot Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Application (2021-2032) Figure 27. Global Neurorehabilitation Exoskeleton Robot Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Neurorehabilitation Exoskeleton Robot Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Neurorehabilitation Exoskeleton Robot Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 32. North America Neurorehabilitation Exoskeleton Robot Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Neurorehabilitation Exoskeleton Robot Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Neurorehabilitation Exoskeleton Robot Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 38. South America Neurorehabilitation Exoskeleton Robot Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Neurorehabilitation Exoskeleton Robot Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Neurorehabilitation Exoskeleton Robot Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Neurorehabilitation Exoskeleton Robot Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Body Rehabilitation Exoskeleton
  • Upper Limb Rehabilitation Exoskeleton
  • Lower Limb Rehabilitation Exoskeleton
Applications
  • Hospital
  • Rehabilitation Center
  • Others
Companies covered
  • Shanghai Real Star Rehabilitation Equipment
  • Shanghai Xirun Medical Equipment
  • Beijing AI- robotics Technology
  • Angelexo Scientific
  • Myomo
  • Hocoma
  • Focal Meditech
  • Ekso Bionics
  • Bionik
  • AlterG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  4. 1.2.2 Global Neurorehabilitation Exoskeleton Robot Sales Volume (2021-2032)
  5. 1.2.3 Global Neurorehabilitation Exoskeleton Robot Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurorehabilitation Exoskeleton Robot Market Dynamics
  1. 2.1 Neurorehabilitation Exoskeleton Robot Industry Trends
  2. 2.2 Neurorehabilitation Exoskeleton Robot Industry Drivers
  3. 2.3 Neurorehabilitation Exoskeleton Robot Industry Opportunities and Challenges
  4. 2.4 Neurorehabilitation Exoskeleton Robot Industry Restraints
3 Neurorehabilitation Exoskeleton Robot Market by Company
  1. 3.1 Global Neurorehabilitation Exoskeleton Robot Company Revenue Ranking in 2025
  2. 3.2 Global Neurorehabilitation Exoskeleton Robot Revenue by Company (2021-2026)
  3. 3.3 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurorehabilitation Exoskeleton Robot Average Price by Company (2021-2026)
  5. 3.5 Global Neurorehabilitation Exoskeleton Robot Company Ranking (2024-2026)
  6. 3.6 Global Neurorehabilitation Exoskeleton Robot Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurorehabilitation Exoskeleton Robot Company Product Type and Application
  8. 3.8 Global Neurorehabilitation Exoskeleton Robot Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurorehabilitation Exoskeleton Robot Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurorehabilitation Exoskeleton Robot Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurorehabilitation Exoskeleton Robot Market by Type
  1. 4.1 Neurorehabilitation Exoskeleton Robot Type Introduction
  2. 4.1.1 Whole Body Rehabilitation Exoskeleton
  3. 4.1.2 Upper Limb Rehabilitation Exoskeleton
  4. 4.1.3 Lower Limb Rehabilitation Exoskeleton
  5. 4.2 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type
  6. 4.2.1 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Neurorehabilitation Exoskeleton Robot Sales Value by Type
  10. 4.3.1 Global Neurorehabilitation Exoskeleton Robot Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Neurorehabilitation Exoskeleton Robot Sales Value by Type (2021-2032)
  12. 4.3.3 Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Type (2021-2032)
5 Neurorehabilitation Exoskeleton Robot Market by Application
  1. 5.1 Neurorehabilitation Exoskeleton Robot Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Rehabilitation Center
  4. 5.1.3 Others
  5. 5.2 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application
  6. 5.2.1 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurorehabilitation Exoskeleton Robot Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Neurorehabilitation Exoskeleton Robot Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Neurorehabilitation Exoskeleton Robot Sales Value by Application
  10. 5.3.1 Global Neurorehabilitation Exoskeleton Robot Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurorehabilitation Exoskeleton Robot Sales Value by Application (2021-2032)
  12. 5.3.3 Global Neurorehabilitation Exoskeleton Robot Sales Value Share by Application (2021-2032)
6 Neurorehabilitation Exoskeleton Robot Regional Sales and Value Analysis
  1. 6.1 Global Neurorehabilitation Exoskeleton Robot Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurorehabilitation Exoskeleton Robot Sales by Region (2021-2032)
  3. 6.2.1 Global Neurorehabilitation Exoskeleton Robot Sales by Region: 2021-2026
  4. 6.2.2 Global Neurorehabilitation Exoskeleton Robot Sales by Region (2027-2032)
  5. 6.3 Global Neurorehabilitation Exoskeleton Robot Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurorehabilitation Exoskeleton Robot Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurorehabilitation Exoskeleton Robot Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurorehabilitation Exoskeleton Robot Sales Value by Region (2027-2032)
  9. 6.5 Global Neurorehabilitation Exoskeleton Robot Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  12. 6.6.2 North America Neurorehabilitation Exoskeleton Robot Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  15. 6.7.2 Europe Neurorehabilitation Exoskeleton Robot Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurorehabilitation Exoskeleton Robot Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  21. 6.9.2 South America Neurorehabilitation Exoskeleton Robot Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurorehabilitation Exoskeleton Robot Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurorehabilitation Exoskeleton Robot Sales Value Share by Country, 2025 VS 2032
7 Neurorehabilitation Exoskeleton Robot Country-level Sales and Value Analysis
  1. 7.1 Global Neurorehabilitation Exoskeleton Robot Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurorehabilitation Exoskeleton Robot Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurorehabilitation Exoskeleton Robot Sales by Country (2021-2032)
  4. 7.3.1 Global Neurorehabilitation Exoskeleton Robot Sales by Country (2021-2026)
  5. 7.3.2 Global Neurorehabilitation Exoskeleton Robot Sales by Country (2027-2032)
  6. 7.4 Global Neurorehabilitation Exoskeleton Robot Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurorehabilitation Exoskeleton Robot Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurorehabilitation Exoskeleton Robot Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurorehabilitation Exoskeleton Robot Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurorehabilitation Exoskeleton Robot Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurorehabilitation Exoskeleton Robot Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Real Star Rehabilitation Equipment
  2. 8.1.1 Shanghai Real Star Rehabilitation Equipment Company Information
  3. 8.1.2 Shanghai Real Star Rehabilitation Equipment Business Overview
  4. 8.1.3 Shanghai Real Star Rehabilitation Equipment Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Real Star Rehabilitation Equipment Neurorehabilitation Exoskeleton Robot Product Portfolio
  6. 8.1.5 Shanghai Real Star Rehabilitation Equipment Recent Developments
  7. 8.2 Shanghai Xirun Medical Equipment
  8. 8.2.1 Shanghai Xirun Medical Equipment Company Information
  9. 8.2.2 Shanghai Xirun Medical Equipment Business Overview
  10. 8.2.3 Shanghai Xirun Medical Equipment Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Xirun Medical Equipment Neurorehabilitation Exoskeleton Robot Product Portfolio
  12. 8.2.5 Shanghai Xirun Medical Equipment Recent Developments
  13. 8.3 Beijing AI- robotics Technology
  14. 8.3.1 Beijing AI- robotics Technology Company Information
  15. 8.3.2 Beijing AI- robotics Technology Business Overview
  16. 8.3.3 Beijing AI- robotics Technology Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing AI- robotics Technology Neurorehabilitation Exoskeleton Robot Product Portfolio
  18. 8.3.5 Beijing AI- robotics Technology Recent Developments
  19. 8.4 Angelexo Scientific
  20. 8.4.1 Angelexo Scientific Company Information
  21. 8.4.2 Angelexo Scientific Business Overview
  22. 8.4.3 Angelexo Scientific Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Angelexo Scientific Neurorehabilitation Exoskeleton Robot Product Portfolio
  24. 8.4.5 Angelexo Scientific Recent Developments
  25. 8.5 Myomo
  26. 8.5.1 Myomo Company Information
  27. 8.5.2 Myomo Business Overview
  28. 8.5.3 Myomo Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Myomo Neurorehabilitation Exoskeleton Robot Product Portfolio
  30. 8.5.5 Myomo Recent Developments
  31. 8.6 Hocoma
  32. 8.6.1 Hocoma Company Information
  33. 8.6.2 Hocoma Business Overview
  34. 8.6.3 Hocoma Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hocoma Neurorehabilitation Exoskeleton Robot Product Portfolio
  36. 8.6.5 Hocoma Recent Developments
  37. 8.7 Focal Meditech
  38. 8.7.1 Focal Meditech Company Information
  39. 8.7.2 Focal Meditech Business Overview
  40. 8.7.3 Focal Meditech Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Focal Meditech Neurorehabilitation Exoskeleton Robot Product Portfolio
  42. 8.7.5 Focal Meditech Recent Developments
  43. 8.8 Ekso Bionics
  44. 8.8.1 Ekso Bionics Company Information
  45. 8.8.2 Ekso Bionics Business Overview
  46. 8.8.3 Ekso Bionics Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ekso Bionics Neurorehabilitation Exoskeleton Robot Product Portfolio
  48. 8.8.5 Ekso Bionics Recent Developments
  49. 8.9 Bionik
  50. 8.9.1 Bionik Company Information
  51. 8.9.2 Bionik Business Overview
  52. 8.9.3 Bionik Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bionik Neurorehabilitation Exoskeleton Robot Product Portfolio
  54. 8.9.5 Bionik Recent Developments
  55. 8.10 AlterG
  56. 8.10.1 AlterG Company Information
  57. 8.10.2 AlterG Business Overview
  58. 8.10.3 AlterG Neurorehabilitation Exoskeleton Robot Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AlterG Neurorehabilitation Exoskeleton Robot Product Portfolio
  60. 8.10.5 AlterG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurorehabilitation Exoskeleton Robot Value Chain Analysis
  2. 9.1.1 Neurorehabilitation Exoskeleton Robot Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurorehabilitation Exoskeleton Robot Sales Mode & Process
  6. 9.2 Neurorehabilitation Exoskeleton Robot Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurorehabilitation Exoskeleton Robot Distributors
  9. 9.2.3 Neurorehabilitation Exoskeleton Robot Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst